IRIS - Res&Arch Institutional Research Information System - Research & Archive

BECATTINI, Cecilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.582
EU - Europa 2.593
AS - Asia 748
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
Totale 6.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.572
IE - Irlanda 790
IT - Italia 635
UA - Ucraina 340
VN - Vietnam 295
HK - Hong Kong 275
SE - Svezia 245
FI - Finlandia 144
RU - Federazione Russa 132
DE - Germania 107
CN - Cina 87
GB - Regno Unito 56
FR - Francia 48
TR - Turchia 41
CH - Svizzera 26
AT - Austria 16
SG - Singapore 16
LB - Libano 13
UZ - Uzbekistan 11
BE - Belgio 10
CA - Canada 9
NL - Olanda 9
GR - Grecia 8
MK - Macedonia 8
ES - Italia 5
PL - Polonia 5
CL - Cile 4
EU - Europa 4
JP - Giappone 3
KR - Corea 3
BG - Bulgaria 2
BR - Brasile 2
IN - India 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
OM - Oman 1
RS - Serbia 1
TN - Tunisia 1
Totale 6.937
Salva come PNG Salva come JPEG
Città #
Chandler 858
Dublin 788
San Mateo 380
Dong Ket 295
Hong Kong 274
Altamura 221
Medford 196
Princeton 196
Lawrence 190
Perugia 180
Jacksonville 179
Ann Arbor 133
Wilmington 129
Des Moines 107
Andover 101
Beijing 78
Redmond 53
San Paolo di Civitate 51
Ashburn 47
Los Angeles 42
Saint Petersburg 42
Izmir 38
Norwalk 37
Helsinki 28
Falls Church 24
Amelia 19
Redwood City 17
Rome 17
Moscow 13
Woodbridge 13
Brussels 10
Lappeenranta 9
New York 9
Hanover 8
Shanghai 8
Singapore 8
Boardman 7
Auburn Hills 6
Chicago 6
Den Haag 6
Houston 5
Lausanne 5
Frankfurt Am Main 4
Kiev 4
Ottawa 4
Philadelphia 4
Ponte 4
Toledo 4
Amsterdam 3
Bologna 3
Milan 3
Seattle 3
Seoul 3
Skopje 3
Vienna 3
Antalya 2
Bardovci 2
Castello di Godego 2
Córdoba 2
Falconara Marittima 2
Ludwigshafen am Rhein 2
Madrid 2
Manfredonia 2
Menlo Park 2
Padova 2
Palermo 2
Parabiago 2
Paris 2
Piediluco 2
Pisa 2
Rostock 2
Salerno 2
San Diego 2
San Giorgio Ionico 2
San Jose 2
Simi Valley 2
Sofia 2
Terni 2
Toronto 2
Abbadia 1
Aberdeen 1
Albignasego 1
Angra dos Reis 1
Ashington 1
Assisi 1
Augusta 1
Ballina 1
Bastia 1
Berlin 1
Birmingham 1
Bucharest 1
Budapest 1
Buffalo 1
Buggiano 1
Cairo 1
Cannock 1
Cantonment 1
Carlow 1
Carrion de los Cespedes 1
Casalnuovo Di Napoli 1
Totale 4.947
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 93
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 90
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 81
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 74
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 70
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 66
Risk factors for adverse short-term outcome in patients with pulmonary embolism 65
Aspirin for preventing the recurrence of venous thromboembolism. 65
Acute pulmonary embolism: risk stratification in the emergency department. 65
Thrombolysis in submassive pulmonary embolism 65
Initial treatment of venous thromboembolism 63
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 63
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 62
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 62
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 61
A prospective study on cardiovascular events after acute pulmonary embolism 57
Acute pulmonary embolism. 57
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 57
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 56
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. 56
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 55
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 55
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 55
Recurrent venous thromboembolism in men and women 54
New anticoagulants 54
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. 54
Combined oral anticoagulants and antiplatelets: benefits and risks. 54
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. 54
Aspirin for the prevention of recurrent venous thromboembolism the INSPIRE collaboration 53
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 53
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 53
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing 52
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 51
D-dimer for riskstratification in patients with acute pulmonary embolism. 51
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism] 51
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 51
Acute pulmonary embolism: external validation of an integrated risk stratification model. 49
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 49
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 49
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 48
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 48
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 48
Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY 48
Extended oral anticoagulant therapy after a first episode of pulmonary embolism. 47
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 47
Predictors of mortality from pulmonary embolism andtheir influence on clinical management. 47
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 47
ANMCO statement: Arterial and venous thromboembolism: What implications for clinical practice? 47
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) 47
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 47
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 46
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: Systematic review and meta-analysis 46
Acute treatment of venous thromboembolism 46
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 46
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 46
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism 45
Duration of anticoagulant treatment after venous thromboembolism. 45
Anticoagulant treatment for acute pulmonary embolism: A pathophysiology-based clinical approach 45
Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial 45
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 44
Reply 44
Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis 44
Pathogenesis of venous thromboembolism 43
Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study 43
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 43
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 43
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 43
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 43
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 43
Clinical and economic aspects of managing venous thromboembolism in the outpatient setting 43
New oral anticoagulants for venous thromboembolism: focus on factor Xa and thrombin inhibitors. 42
Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment 42
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 42
Long-term therapy of pulmonary embolism 42
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 42
Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis 42
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 41
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 41
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 41
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 40
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients 40
Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. 39
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 39
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 39
Apixaban for the treatment of venous thromboembolism associated with cancer 39
Treatment of DVT: how long is enough and how do you predict recurrence. 38
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 38
Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. 37
ECOGRAFICA TRANS-TORACICA NELLA VALUTAZIONE DEI FLUIDI POLMONARI EXTRAVASCOLARI DOPO CHIRURGIA TORACICA MAGGIORE 37
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism 37
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 37
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 37
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 37
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 37
The EINSTEIN CHOICE study 36
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 36
Lo studio EINSTEIN CHOICE 36
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 35
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis 35
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 35
Totale 4.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201944 0 0 0 0 0 0 0 0 0 0 44 0
2019/2020412 10 26 50 8 46 3 48 12 78 79 30 22
2020/20211.127 5 49 22 49 383 40 72 17 80 41 64 305
2021/20221.551 27 258 20 50 80 19 14 454 47 111 219 252
2022/20232.935 217 636 38 202 223 342 0 107 1.037 13 88 32
2023/2024690 77 108 69 14 12 5 248 32 66 58 1 0
Totale 7.379